Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.57 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395273 | 0.90 | ALDH1A1 (0.69) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL5461723 | 0.89 | ALDH1A1 (0.67) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL23768639 | 0.89 | LPAR1 (0.58) | LPAR1LPAR3 | |
| SCHEMBL24208086 | 0.88 | LPAR1 (0.49) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL21326401 | 0.86 | ALDH1A1 (0.63) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL26566666 | 0.86 | ALDH1A1 (0.63) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL9718817 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL4094364 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL2782935 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CNR1CNR2LPAR1LPAR3 | |
| SCHEMBL2782946 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CNR1CNR2LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220396548-A1 | IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY | GLOBAL LIFE SCIENCES SOLUTIONS CANADA ULC (CA) | 2022-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396548-A1 | IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY | RNASEH1, NSUN3, SLC67A1 | ALDH1A1 2638/4885CNR1 3180/4885CNR2 4097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.